Could be the key stock for 202123 Dec 2020 07:29
I've been a LTH here since a earlier this year, been via the highs and lows. This AVA6000 release, as expected, is the reason why I expect AVCT to be the main driver of my PF in 2021. It's not just Covid peeps, it never has been. Positive progress with AVA6000 can potentially be a many-times multiplier, and add that to what, by say the end of Q1, will be the realisation that AVCT's covid work has been real after all, with solidifying evidence of world-class and now commercialized test, you'll be happy to have held. All IMHO of course.